Despite ceCT remains the clinical guideline recommendation, PET/CT is suggested in the workup of recurrent CRC patients with metachronous metastases, or elevated serial CEA but negative conventional imaging modalities and optical colonoscopy. The gene discussed is CEACAM5; the disease is colorectal carcinoma.